Piloting the options assessment toolkit with national malaria programme leaders from the Asia–Pacific countries: a meeting report
Issued Date
2025-12-01
Resource Type
eISSN
14752875
Scopus ID
2-s2.0-105008192549
Journal Title
Malaria Journal
Volume
24
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Malaria Journal Vol.24 No.1 (2025)
Suggested Citation
Shrestha M., Acharya S., Neukom J., Lhazeen K., Thang N.D., Habib M.N., Wini L., Tobgyel T., Wangchuk K., Rekol H., Dysoley L., Sovannaroth S., Simatuopang M., Prameswari H.D., Surya A., Ring Z., Khan M.Q., Khamlome B., Hamid M.H.A., Mahato R.K., Thapa T., Juangco S.A., Lee H.I., Shin H.I., Gunasekera K., Aluthwera C., Sudathip P., Timpontree R., Canh H.D., Cheung S., Haroon M.Z., Acharya S., Commons R.J., Adhikari B., Ruwanpura V., Hein P.S., Sharma A., Aung P.P., Valecha N., Thriemer K., Lynch C.A. Piloting the options assessment toolkit with national malaria programme leaders from the Asia–Pacific countries: a meeting report. Malaria Journal Vol.24 No.1 (2025). doi:10.1186/s12936-025-05432-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/110890
Title
Piloting the options assessment toolkit with national malaria programme leaders from the Asia–Pacific countries: a meeting report
Author(s)
Shrestha M.
Acharya S.
Neukom J.
Lhazeen K.
Thang N.D.
Habib M.N.
Wini L.
Tobgyel T.
Wangchuk K.
Rekol H.
Dysoley L.
Sovannaroth S.
Simatuopang M.
Prameswari H.D.
Surya A.
Ring Z.
Khan M.Q.
Khamlome B.
Hamid M.H.A.
Mahato R.K.
Thapa T.
Juangco S.A.
Lee H.I.
Shin H.I.
Gunasekera K.
Aluthwera C.
Sudathip P.
Timpontree R.
Canh H.D.
Cheung S.
Haroon M.Z.
Acharya S.
Commons R.J.
Adhikari B.
Ruwanpura V.
Hein P.S.
Sharma A.
Aung P.P.
Valecha N.
Thriemer K.
Lynch C.A.
Acharya S.
Neukom J.
Lhazeen K.
Thang N.D.
Habib M.N.
Wini L.
Tobgyel T.
Wangchuk K.
Rekol H.
Dysoley L.
Sovannaroth S.
Simatuopang M.
Prameswari H.D.
Surya A.
Ring Z.
Khan M.Q.
Khamlome B.
Hamid M.H.A.
Mahato R.K.
Thapa T.
Juangco S.A.
Lee H.I.
Shin H.I.
Gunasekera K.
Aluthwera C.
Sudathip P.
Timpontree R.
Canh H.D.
Cheung S.
Haroon M.Z.
Acharya S.
Commons R.J.
Adhikari B.
Ruwanpura V.
Hein P.S.
Sharma A.
Aung P.P.
Valecha N.
Thriemer K.
Lynch C.A.
Author's Affiliation
Menzies School of Health Research
Thailand Ministry of Public Health
Kementerian Kesihatan Malaysia
Mahidol Oxford Tropical Medicine Research Unit
Korea Disease Control and Prevention Agency
Kementerian Kesehatan Republik Indonesia
Clinton Health Access Initiative, Inc.
Ministry of Health Colombo
Ministry of Health Vitenam
Ayub Medical College
Minister for Health and Population Nepal
Department of Health Manila
Ministry of Public Health
Ministry of Health Laos
Ministry of Health
Ministry of Health and Medical Services
PATH
Entomology
Asia Pacific Malaria Elimination Network (APMEN)
MMV Medicines for Malaria Venture
Malaria Consortium
APLMA Consultant
Provincial Malaria Program
Regional Malaria CSO Platform
Ministry of Health and Sports
Thailand Ministry of Public Health
Kementerian Kesihatan Malaysia
Mahidol Oxford Tropical Medicine Research Unit
Korea Disease Control and Prevention Agency
Kementerian Kesehatan Republik Indonesia
Clinton Health Access Initiative, Inc.
Ministry of Health Colombo
Ministry of Health Vitenam
Ayub Medical College
Minister for Health and Population Nepal
Department of Health Manila
Ministry of Public Health
Ministry of Health Laos
Ministry of Health
Ministry of Health and Medical Services
PATH
Entomology
Asia Pacific Malaria Elimination Network (APMEN)
MMV Medicines for Malaria Venture
Malaria Consortium
APLMA Consultant
Provincial Malaria Program
Regional Malaria CSO Platform
Ministry of Health and Sports
Corresponding Author(s)
Other Contributor(s)
Abstract
Plasmodium vivax malaria remains a major challenge in the Asia–Pacific region, where National Malaria Programmes (NMPs) will need to determine optimal radical cure strategies given the availability of novel options, such as high-dose primaquine and tafenoquine. The Options Assessment Toolkit (OAT) was developed to assist NMPs to make decisions on the optimal combination of G6PD testing and radical cure drug regimen. This study reports on the piloting of OAT with NMP representatives during the APMEN Vivax Working Group Annual Meeting in December 2022. A total of 23 NMP representatives from 13 Asia–Pacific countries participated in facilitated discussions. Thematic analysis of qualitative data revealed that NMPs found the OAT useful and timely for structuring malaria policy discussions. However, concerns were raised regarding mismatches between OAT-generated scenarios and country-specific contexts, the inclusion of political and economic factors, and the feasibility of implementing expert-suggested options. Many NMPs expressed enthusiasm for single-dose tafenoquine, but preferred to await WHO recommendations before considering policy changes. Overall, the OAT was well received as a tool for initiating policy discussions on P. vivax radical cure. The OAT represents an important step toward accelerating evidence-based policy change in malaria-endemic countries, with further refinements enhancing its utility.
